BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Diagnosis
10 results:

  • 1. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
    Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
    JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
    Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Recurrent Undifferentiated Carcinoma of the Sella in a Patient with Lynch Syndrome.
    Voisin MR; Almeida JP; Perez-Ordonez B; Zadeh G
    World Neurosurg; 2019 Dec; 132():219-222. PubMed ID: 31491579
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom.
    Cea Soriano L; Zong J; García Rodríguez LA
    BMC Cancer; 2019 Jan; 19(1):91. PubMed ID: 30665371
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.
    Wagner AH; Devarakonda S; Skidmore ZL; Krysiak K; Ramu A; Trani L; Kunisaki J; Masood A; Waqar SN; Spies NC; Morgensztern D; Waligorski J; Ponce J; Fulton RS; Maggi LB; Weber JD; Watson MA; O'Conor CJ; Ritter JH; Olsen RR; Cheng H; Mukhopadhyay A; Can I; Cessna MH; Oliver TG; Mardis ER; Wilson RK; Griffith M; Griffith OL; Govindan R
    Nat Commun; 2018 Sep; 9(1):3787. PubMed ID: 30224629
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes.
    Ponz de Leon M; Pedroni M; Pezzi A; Sulce B; Roncucci L; Domati F; Rossi G; Reggiani Bonetti L
    Scand J Gastroenterol; 2018 Jan; 53(1):31-37. PubMed ID: 29025352
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inherited Mutations in Women With Ovarian Carcinoma.
    Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ
    JAMA Oncol; 2016 Apr; 2(4):482-90. PubMed ID: 26720728
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Advances in the study of Lynch syndrome in China.
    Lu JY; Sheng JQ
    World J Gastroenterol; 2015 Jun; 21(22):6861-71. PubMed ID: 26078562
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
    Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
    Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
    Quintás-Cardama A; Lazar AJ; Woodman SE; Kim K; Ross M; Hwu P
    Nat Clin Pract Oncol; 2008 Dec; 5(12):737-40. PubMed ID: 18936790
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.